160 related articles for article (PubMed ID: 11360218)
1. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
Cohen DE; Walker BD
Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H; Matano T
Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
Deeks SG; Walker BD
Immunity; 2007 Sep; 27(3):406-16. PubMed ID: 17892849
[TBL] [Abstract][Full Text] [Related]
4. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
Gupta S; Mitra D
Indian J Biochem Biophys; 2007 Oct; 44(5):269-75. PubMed ID: 18341200
[TBL] [Abstract][Full Text] [Related]
6. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
[TBL] [Abstract][Full Text] [Related]
7. Virology and immunology of acute HIV type 1 infection.
Daar ES
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S229-34. PubMed ID: 9814948
[TBL] [Abstract][Full Text] [Related]
8. HIV and children: the developing immune system fights back.
Feeney ME
West Indian Med J; 2004 Oct; 53(5):359-62. PubMed ID: 15675505
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis and immunotherapy in AIDS virus infections.
Letvin NL; Walker BD
Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
[TBL] [Abstract][Full Text] [Related]
10. Dichotomy in cross-clade reactivity and neutralization by HIV-1 sera: Implications for active and passive immunotherapy.
Cavacini LA; Duval M; Patil A; Wood C; Mayer KH; Ruprecht RM; Posner MR
J Med Virol; 2005 Jun; 76(2):146-52. PubMed ID: 15834877
[TBL] [Abstract][Full Text] [Related]
11. Living in oblivion: HIV immune evasion.
Piguet V; Trono D
Semin Immunol; 2001 Feb; 13(1):51-7. PubMed ID: 11289799
[TBL] [Abstract][Full Text] [Related]
12. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
13. HIV-specific CD4+ T cells and viremia: who's in control?
Jansen CA; van Baarle D; Miedema F
Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
[TBL] [Abstract][Full Text] [Related]
14. Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.
Koning FA; Kwa D; Boeser-Nunnink B; Dekker J; Vingerhoed J; Hiemstra H; Schuitemaker H
J Infect Dis; 2003 Sep; 188(6):864-72. PubMed ID: 12964118
[TBL] [Abstract][Full Text] [Related]
15. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
Sheppard N; Sattentau Q
Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
[TBL] [Abstract][Full Text] [Related]
16. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
17. Understanding the mechanisms and limitations of immune control of HIV.
Davenport MP; Ribeiro RM; Zhang L; Wilson DP; Perelson AS
Immunol Rev; 2007 Apr; 216():164-75. PubMed ID: 17367342
[TBL] [Abstract][Full Text] [Related]
18. Immunodominance of HIV-1-specific CD8(+) T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics.
Lichterfeld M; Yu XG; Le Gall S; Altfeld M
Trends Immunol; 2005 Mar; 26(3):166-71. PubMed ID: 15745859
[TBL] [Abstract][Full Text] [Related]
19. Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10.
Mehandru S; Wrin T; Galovich J; Stiegler G; Vcelar B; Hurley A; Hogan C; Vasan S; Katinger H; Petropoulos CJ; Markowitz M
J Virol; 2004 Dec; 78(24):14039-42. PubMed ID: 15564511
[TBL] [Abstract][Full Text] [Related]
20. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
Shimizu Y; Miyazaki Y; Ibuki K; Suzuki H; Kaneyasu K; Goto Y; Hayami M; Miura T; Haga T
Virology; 2005 Dec; 343(2):151-61. PubMed ID: 16169034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]